Objective To combine a comprehensive ultrasound study with multiple marker
screening to identify fetuses with triploidy.
Study design A retrospective review of cases with prenatal diagnosis of fet
al triploidy was carried out.
Data were gathered from a combination of medical records, autopsy pathology
, ultrasound and cytogenetic reports. Maternal serum a-fetoprotein (AFP), u
nconjugated estriol and human chorionic gonadotropin (hCG) levels were corr
elated with placental;and fetal phenotypes. Chromosomal heteromorphism from
Q-banded preparations was used to determine the parental origin.
Results Nine patients matched all inclusion criteria defined, and served as
the population base for this study. There were five cases with a 69,XXX ka
ryotype and four cases with a 69,XXY karyotype. Mean maternal age was 24.9
+/- 5.3 years (range 16-31 years). Mean gestational age at referral was 18.
3+/-2.6 weeks (range 15.3-22.9 weeks). Three cases were referred because of
increased risk for both trisomy 21 and open neural tube defect. The other
six cases were referred for increased risk for trisomy 18. The amniotic flu
id AFP level was within the normal range for all but one case with elevated
maternal serum AFP. Normal fetal growth or mild symmetric intrauterine gro
wth restriction was found to coincide with both high levels of hCG and AFP,
large cystic placenta and a paternal extra set of chromosomes. Severe asym
metric intrauterine growth restriction with head circumference/abdominal ci
rcumference ratio > 95% was found to coincide with low hCG level, non-cysti
c small placenta and a maternal extra set of chromosomes.
Conclusion The combination of second-trimester multiple marker screening an
d ultrasound can identify triploid conceptuses. A correlation can be seen b
etween the ultrasound findings, maternal serum level of AFP, unconjugated e
striol and hCG, and parental origin of the extra set of chromosomes in trip
loid conceptuses.